Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 23 (RPL31P23)

Target: RPL31P23
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L31 pseudogene 23 (RPL31P23) is a processed pseudogene of the ribosomal protein L31 gene, does not encode a functional protein, and has no recognized biological or disease association or value as a drug target.

Other names: RPL31_5_407RPL31P23

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 23 (RPL31P23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 23 (RPL31P23).

Explore the full profile